title: [The efficacy of heparin therapy in patients with diabetic glomerulosclerosis].
abstract: Heparin therapy (25,000 U/day) of 38 patients with diabetic glomerulosclerosis resulted in improvement in 31 (82 +/- 6%). The treatment was not effective in 5% and complications were seen in 2 patients. Blood coagulation control is necessary during heparin treatment and turbidimetry proved to be highly informative in objective registration of coagulation and fibrinolysis processes.
authors.forename: L A
authors.initials: LA
authors.lastname: Pyrih
authors.forename: I I
authors.initials: II
authors.lastname: Lapchyns'ka
authors.forename: H O
authors.initials: HO
authors.lastname: Belyts'ka
authors.forename: T I
authors.initials: TI
authors.lastname: Lezhen
mesh_terms: D000328:Adult; D001780:Blood Coagulation Tests; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications; D003928:Diabetic Nephropathies / Q000097:blood / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D005923:Glomerulosclerosis, Focal Segmental / Q000097:blood / Q000188:drug therapy*; D006487:Hemostasis / Q000187:drug effects; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D013997:Time Factors
chemical_list: D006493:Heparin
vernacular_title: Efektyvnist' heparynoterapiï khvorykh na diabetychnyĭ hlomeruloskleroz.